2011 annual financial data

Nektar Therapeutics 2011 Financial results

Direct answer

Revenue was 71,480,000 USD.

Operating income was -123,937,000 USD and net income was -133,978,000 USD.
Operating cash flow was -113,742,000 USD.

Get free Nektar Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
71,480,000 USD
Operating income
-123,937,000 USD
Net income
-133,978,000 USD
Operating cash flow
-113,742,000 USD